TreatGut

TreatGut Biotechnology (Guangzhou) Co., Ltd. (referred to as TreatGut) was established in 2016 with the mission of "Integrating Microecology, Revitalizing Great Health." It focuses on the research, development, and industrialization of technologies and products related to fecal microbiota transplantation and intestinal microecology. As China's first national high-tech enterprise, it provides a comprehensive precision microbiota transplantation solution.TreatGut has now established a wholly-owned subsidiary in Xiamen, equipped with a complete gene sequencing platform and a professional bioinformatics analysis team. Leveraging its unique advantages in gut microbiota research and development, TreatGut has built an integrated service system targeting intestinal microecology, encompassing prevention, diagnosis, microbiota transplantation treatment, and post-treatment evaluation, continuously contributing to the industry and redefining microecological health for humanity.